Holen Sie sich die Stockscreener-App
178.47
2.18%
3.80
Handel nachbörslich:
178.47
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$174.67
Offen:
$175.38
24-Stunden-Volumen:
519.84K
Relative Volume:
0.64
Marktkapitalisierung:
$11.39B
Einnahmen:
$13.84B
Nettoeinkommen (Verlust:
$1.10B
KGV:
17.13
EPS:
10.4185
Netto-Cashflow:
$1.49B
1W Leistung:
-2.93%
1M Leistung:
+0.38%
6M Leistung:
+15.06%
1J Leistung:
+37.00%
1-Tages-Spanne:
$174.67
$179.10
1-Wochen-Bereich:
$174.31
$186.23
52-Wochen-Spanne:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, EHC, FMS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
178.47 | 11.14B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
435.61 | 91.68B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
259.71 | 20.09B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
123.47 | 12.04B | 6.07B | 793.80M | 464.40M | 5.9914 |
FMS
Fresenius Medical Care Ag Adr
|
22.69 | 11.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Form 4 DaVita HealthCare Partners For: 25 September By Investing.com - Investing.com Canada
Is DaVita Stock Underperforming the S&P 500? - webull.com
DaVita stock heads into the open after September 24 loss - AD HOC NEWS
DaVita Inc (DVA) Shares Fall 4.6% -- What GF Score of 92 Tells I - GuruFocus
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
DaVita stock heads into the open after a 0.55 percent gain - AD HOC NEWS
Fred Hutch buys former DaVita building in Federal Way for $18 million - The Business Journals
DaVita stock gains 1.08 percent as Q2 EPS beats consensus - AD HOC NEWS
DaVita stock holds above USD 183 as earnings estimates rise - AD HOC NEWS
DaVita stock slips 0.65 percent ahead of the open - AD HOC NEWS
DaVita Inc. stock slips 0.65 percent as earnings support outlook - AD HOC NEWS
DaVita stock falls 0.65 percent as earnings growth supports outlook - AD HOC NEWS
DaVita stock heads into the open after a 0.3 percent gain - AD HOC NEWS
DaVita Inc. stock gains after strong Q2 results and upbeat outlook - AD HOC NEWS
3 Surging Stocks That Don’t Need the AI Boom to Keep Winning - inkl.com
DaVita Inc. (DVA) Stock Analysis: Uncovering a 19.58% Upside Within the Healthcare Sector - DirectorsTalk Interviews
DaVita Inc. stock holds recent gains on strong Q2 2026 results and EPS guidance - AD HOC NEWS
DaVita Inc. stock gains on strong Q2 2026 results and upbeat guidance - AD HOC NEWS
DaVita stock softens as investors weigh FY 2026 EPS guidance and market cap - AD HOC NEWS
DaVita Inc. stock falls after 5.6 percent slide and Bank of America stake - ad-hoc-news.de
DaVita Inc (DVA) Shares Fall 5.6% -- What GF Score of 91 Tells I - GuruFocus
DaVita Slides as Recent Rally Cools Without an Obvious Fresh Catalyst - Moomoo
DaVita slides as recent rally cools without an obvious fresh catalyst - Quiver Quantitative
DaVita stock gains as 2026 guidance beats estimates - AD HOC NEWS
DaVita stock heads into the open after a 1.6% gain - AD HOC NEWS
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita stock heads into the open after a 4.4% gain - AD HOC NEWS
A Look at DaVita Inc (DVA) After 4.3% Gain -- GF Value $195.67 v - GuruFocus
DaVita Inc. (DVA) Stock Analysis: Assessing a 20% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
DaVita (DVA) Q2 2026 Earnings Call Transcript - Fortune
DaVita Inc. stock advances as Q2 2026 earnings and guidance underpin strong valuation - ad-hoc-news.de
DaVita Community Care Report 2025: Our Journey to Net Zero - ACCESS Newswire
DaVita stock heads into the open after a 1.9% gain - ad-hoc-news.de
DaVita to pay $15M to settle data breach lawsuit - Tri-Cities Area Journal of Business
DaVita Inc. stock gains as guidance and earnings support strong 2026 outlook - ad-hoc-news.de
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Yahoo Finance
DaVita stock heads into the open after a 0.9% gain - ad-hoc-news.de
DaVita Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 - accessnewswire.com
DaVita Inc. stock holds near recent highs on solid Q2 2026 earnings and guidance - ad-hoc-news.de
DaVita stock heads into the open after a flat prior close - ad-hoc-news.de
DaVita Inc. stock gains support from solid Q2 2026 earnings - ad-hoc-news.de
DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK
DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors - DirectorsTalk Interviews
DaVita Inc. stock gains on solid Q1 figures and buybacks - ad-hoc-news.de
DaVita $15M Data Breach Settlement Hits 2.4M Patients - tech-insider.org
DaVita stock gains as Humana expands kidney care - ad-hoc-news.de
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):